Stocks Look To Build On Gains: ViewRay Inc. (VRAY) and Heat Biologics Inc. (HTBX)

The recent price movement of VRAY means that it is now down by -66.91% from its 52-week high and 52.36% up against its 52-week low prices. Over the past one week, the price volatility of VRAY stands at 6.43% while the volatility over the past one month is 8.02%. The beta score for this stock is 1.25. A beta score below 1 means that the stock has a low volatility while above 1 signifies that a stock is highly volatile at that particular moment, a data that traders use to keep tabs on their investments.

The company on 11/12/2019 published its latest quarterly earnings, with the report showing that the company recorded -0.17 earnings per share (EPS) during that period. This report was above the expectations of analysts of -0.23 by 0.06. The revenue by the firm was 18.54M for the quarter.

The shares of ViewRay Inc. (VRAY) gained by 3.53%, leading to a gain of $0.11 per share, and saw VRAY end the trading session at $3.23 on Wednesday 02/05/20. VRAY started the trading session at $3.13, before reaching a daily high of $3.26. It wasn’t able to sustain that growth though and soon jumped to hit a daily low of $3.07.

The trading volume on Wednesday stood at 3649951, which was below the stock’s 3-month average volume of 3.25 million shares, out of a total 108.09M shares. As the price of the stock climbed, the market valuation of the company gained to 479.95 million.

The shares of Heat Biologics Inc. (NASDAQ: HTBX) went up by 0.04% by the end of the recent trading session. This movement saw its price surge to close at $0.26, which was higher than the previous closing price of $0.25. Over the past one week, the price of HTBX has slipped by -0.31%, while it has recorded a loss of -46.84% over the past one month. Its three-month performance saw HTBX lose -51.88% while its six-month performance saw it drop by -60.75%. The situation is different though over the past one year, as the stock price went down by -82.65%, while its year-to-date (YTD) price performance slipped by -46.29%. The stock price has gone up by +11.15% compared to its 90-day low, while it is down -56.02% compared to its 90-day high price.

Let’s take a look at its short, medium and long-term indicators. Composite Indicators shows that Trendspotter rated the stock as a Sell. In the short-term, the stock has a 20-day average volume of 1,896,680 shares, with the short-term indicators averagely rating the stock as a 100% Sell. A look at its medium-term indicators reveals that it has a 50-Day average volume of 881,302 shares and the indicators have an average rating of 100% Sell. The last indicators, the long-term see HTBX stock with a 100-Day average volume of 626,652 shares, giving it an average rating of 100% Sell. A look at the general picture of all short, medium and long-term indicators leaves HTBX with an average rating of 100% Sell.

Several brokerage firms sent out their reports HTBX stock not long ago. In its report sent out on June 20, 2016, ROTH Capital lowered its ratings on HTBX to a Buy. In an earlier report on January 08, 2016, Noble Financial Initiated the stock to a Buy. H.C. Wainwright meanwhile in its report on May 26, 2015 Initiated its rating of the stock to “Buy”.

In related news to the company’s stock, around 5.60% shares are being held by institutional investors. In a recent SEC filing, the company revealed that 14 institutions currently hold the HTBX stock. In the last quarter, a 1,709,934 HTBX shares were in the possession of institutions. On the other hand, the company recorded 3 new institutions who bought it their stock, while 1 institutions sold their entire HTBX reserve. Of the current institutions investing in the stock, 6 increased their investment while 3 decreased their investment in the stock.